Key result
In patients with polycystic ovary syndrome, a BMI ≥27 kg/m2 was not associated with significant differences in HOMA-IR or TSH levels compared to a BMI <27 kg/m2.
Why the study?
Patients with PCOS tend to show insulin resistance and higher circulating insulin levels than matched controls, prompting evaluation of the hormonal alterations through BMI on insulin, IR, and thyroid hormone levels.
Does obesity (BMI ≥ 27 kg/m2) alter insulin resistance and thyroid hormone levels compared to normal/overweight (BMI < 27 kg/m2) in patients with PCOS?
Observational (n=110)
No
Does obesity (BMI ≥ 27 kg/m2) alter insulin resistance and thyroid hormone levels compared to normal/overweight (BMI < 27 kg/m2) in patients with PCOS?
In patients with PCOS, insulin resistance and thyroid hormone levels did not differ significantly between obese and normal/overweight individuals, suggesting hormonal interactions may be independent of adipose tissue.
Answers are grounded in this paper and cite their sources.
May indicate BMI-independent insulin resistance in PCOS; hypothesis-generating and requires prospective validation before clinical adoption.
Introduction: Individuals with polycystic ovary syndrome (PCOS) tend to exhibit insulin resistance and circulating levels of insulin higher than controls matched to obesity levels. The present study aimed to evaluate the hormonal alterations through body mass index (BMI) on the relationship between insulin, insulin resistance (IR), and thyroid hormone levels in PCOS. Materials and Methods: This study is a retrospective clinical analysis study conducted at the department of gynecology and obstetrics between January 2019 and April 2020. PCOS participants were divided into two groups: 59 obese PCOS patients whose BMI value is equal and higher than 27kg/m2; 51 normal or overweight PCOS with BMI less than 27kg/m2. Results: Age factor did not differ between groups (29.8±6 vs 31±7.2; p=0.345). In hormone tests, insulin (14.2±6.8 vs 14.8±8; p=0.688), Homeostatic Model Assessment for Insulin Resistance (HOMA-IR) (3.1±1.4 vs 3.4±1.8; p=0.344), thyroxine (T4)(1.2±0.5 vs 1.2±0.4) and thyroid-stimulating hormone (TSH)(1.9±1.2 vs 1.8±0.9; p=0.848) levels did not differ for BMI groups (p>0.05). Because there was no difference in laboratory comparison for any parameter we analyzed, we could not perform multivariate analysis for further investigations in terms of BMI factor. In the hematological analysis, we did not see any significant alteration for groups. Conclusion: We did not observe any difference between thyroid and IR in the patients who were grouped according to the BMI. PCOS and obesity may be directly related to hormonal interaction rather than adipose tissue.
No takes yet. Share an insight, caveat, or question.
GÜRBÜZ et al. (2021) conducted an observational in Polycystic ovary syndrome (PCOS) (n=110). BMI ≥27 kg/m2 (Obesity) vs. BMI <27 kg/m2 (Normal or overweight) was evaluated on Homeostatic Model Assessment for Insulin Resistance (HOMA-IR) (p=0.344). In patients with polycystic ovary syndrome, a BMI ≥27 kg/m2 was not associated with significant differences in HOMA-IR or TSH levels compared to a BMI <27 kg/m2.
Synapse has enriched 10 related papers. Consider them for comparative context: